From June 10 to 12, 2025, the FCE Pharma - Exposição Internacional de Tecnologia para a Indústria Farmacêutica will take place at S?o Paulo Expo. This event, which has a tradition of over 28 years, is set to be the largest gathering of the pharmaceutical industry in Latin America. With an expected attendance of thousands of professionals and exhibitors, this event promises to be a significant milestone for the industry.

The FCE Pharma 2025 is not just a trade show; it is a platform for networking, learning, and business development. Attendees can explore international trends, innovative technologies, and professional content. The event will feature discussions on risk management in the pharmaceutical industry and the role of biotechnology in agriculture. These topics are crucial for professionals looking to stay ahead in their careers.

Exhibitors at FCE Pharma 2025 will have access to an impressive exhibition area covering more than 100,000 square meters. This space will provide ample opportunity for companies to showcase their latest products and services. The event is also expected to attract over 30,000 exhibitors from around the world.

The FCE Pharma 2025 is organized by NürnbergMesse Brasil, a subsidiary of the NürnbergMesse Group. This group is one of the largest organizers of business events globally, with over 120 international fairs and congresses under its belt. Their expertise ensures that the event will be professionally managed and highly successful.

In addition to the main exhibition area, there will be various talks and discussions that cover a wide range of topics relevant to the pharmaceutical industry. These include conversations on market dynamics, risk management in pharmaceuticals, analytical chemistry, and biobanks. Attendees can also sign up for newsletters to stay updated on the latest news and trends in the pharmaceutical industry.

FCE Pharma 2025 offers a unique opportunity for professionals to network and develop their careers. It is an event that should not be missed by anyone looking to expand their knowledge and business opportunities in the pharmaceutical sector.